NLNG Showcases Mary-Brenda Akoda’s GenScanAI, AI Innovation That Could Cut MRI Scan Time by 90%
The award-winning technology could help hospitals examine more patients, reduce waiting times and improve medical imaging without requiring new MRI equipment.
Mary-Brenda Akoda, winner of the 2026 Nigeria Prize for Science and Innovation (NPSI), has showcased her award-winning innovation, GenScanAI, an artificial intelligence-powered medical imaging solution capable of reducing magnetic resonance imaging (MRI) scan time by up to 90%.
The innovation was presented to medical practitioners, healthcare professionals, researchers, academics, students and technology stakeholders at Vibranium Valley in Ikeja, Lagos, where participants explored its underlying technology and potential applications in healthcare delivery.
GenScanAI uses artificial intelligence and advanced computing techniques to reconstruct MRI images, potentially reducing the time required for examinations while maintaining or improving image quality.
The technology could help hospitals and diagnostic centres increase patient throughput, improve the utilisation of existing MRI equipment and reduce waiting times without the immediate need to invest in additional scanning machines.
Presenting the innovation, Akoda explained the challenges that inspired its development, the technology behind the solution and its potential applications in medical imaging.
The engagement also provided an opportunity for healthcare professionals and researchers to examine its possible practical applications, while students gained insights into how scientific research and digital innovation can address real-world challenges.
Speaking at the event, Sophia Horsfall, NLNG’s General Manager, External Relations and Sustainable Development, said GenScanAI addressed an important healthcare need, particularly as population growth continues to place pressure on diagnostic services.
“Medical imaging plays a critical role in diagnosis and treatment, but the time required for MRI examinations can create delays for patients and limit the number of people healthcare facilities can serve,” Horsfall said.
She noted that innovations such as GenScanAI demonstrate how artificial intelligence and advanced computing can be deployed to tackle practical healthcare challenges and improve the efficiency of existing medical infrastructure.
Horsfall added that the public presentation provided an opportunity to take the innovation beyond the Prize adjudication process by encouraging direct engagement with medical practitioners, researchers and other relevant stakeholders.
According to her, exposing the winning innovation to a wider audience would enable professionals to understand its potential and explore how it could contribute to healthcare delivery.
“The Nigeria Prize for Science and Innovation recognises scientific excellence and encourages solutions to national challenges. Creating opportunities for wider engagement with winning innovations is an important part of bringing their potential benefits to public attention,” she said.
Beyond reducing scanning time, GenScanAI could offer additional benefits through its potential to accommodate patient movement and improve image quality. However, these benefits and its clinical effectiveness would need to be established through appropriate clinical evaluation and validation.
The technology’s potential to shorten MRI examinations could be particularly valuable to healthcare facilities managing high patient volumes, where faster scans could improve operational efficiency and help more patients access diagnostic services.
Akoda emerged as the winner of the 2026 Nigeria Prize for Science and Innovation following an evaluation of more than 230 entries.
The 2026 edition of the Prize focused on “Innovations in Artificial Intelligence or ICT or Digital Technologies for Development,” highlighting the growing role of digital technologies in addressing societal challenges and supporting national development.
NLNG facilitated the public presentation as part of efforts to promote engagement with the winning innovation and encourage discussions about its potential applications.
The event at Vibranium Valley underscored the importance of connecting scientific research with healthcare professionals, research institutions and technology stakeholders who could help translate promising innovations into practical benefits for society.




